Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alte... by Lindley, Anouk, Prager, Gerald, Bitzer, Michael, Burn, Timothy C, Lihou, Christine F, Croft, Elisabeth

Get full text

Longitudinal analysis of extracellular vesicle-associated tissue factor activity in cancer patients by Reitter, Eva-Maria, Kaider, Alexandra, Prager, Gerald, Ay, Cihan, Pabinger, Ingrid, Thaler, Johannes

Get full text

Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer by André, Thierry, Van Cutsem, Eric, Taieb, Julien, Fakih, Marwan, Prager, Gerald W., Ciardiello, Fortunato, Falcone, Alfredo, Saunders, Mark, Amellal, Nadia, Roby, Lucas, Tabernero, Josep, Pfeiffer, Per

Get full text

Angiogenesis in cancer: Anti-VEGF escape mechanisms by Prager, Gerald W., Poettler, Marina, Unseld, Matthias, Zielinski, Christoph C.

Get full text

Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients by Kieler, Markus, Unseld, Matthias, Bianconi, Daniela, Schindl, Martin, Kornek, Gabriela V, Scheithauer, Werner, Prager, Gerald W

Get full text

Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors by Taghizadeh, Hossein, Maj-Hes, Agnieszka, Prager, Gerald W, Müllauer, Leonhard, Mader, Robert M

Get full text

Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy by Wöll, Ewald, Eisterer, Wolfgang, Gerger, Armin, Kühr, Thomas, Prager, Gerald W, Rumpold, Holger, Ulrich-Pur, Herbert, Vogl, Ursula, Winder, Thomas, Weiss, Lukas, Greil, Richard

Get full text

Molecularly guided treatment of metastatic parotid gland carcinoma in adults by Taghizadeh, Hossein, Müllauer, Leonhard, Mader, Robert M., Füreder, Thorsten, Prager, Gerald W.

Get full text

Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib by Unseld, Matthias, Drimmel, Magdalena, Siebenhüner, Alexander, Gleiss, Andreas, Bianconi, Daniela, Kieler, Markus, Scheithauer, Werner, Winder, Thomas, Prager, Gerald W.

Get full text

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma by Taghizadeh, Hossein, Müllauer, Leonhard, Mader, Robert M., Schindl, Martin, Prager, Gerald W.

Get full text

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial by Mair, Maximilian J, Maj-Hes, Agnieszka, Nussbaumer-Pröll, Alina, Puhr, Rainer, Christenheit, Agnieszka, Troch, Marlene, Puhr, Hannah C, Starzer, Angelika M, Steindl, Ariane, Eberl, Sabine, Haslacher, Helmuth, Perkmann, Thomas, Minichsdorfer, Christoph, Prager, Gerald W, Lamm, Wolfgang W, Berghoff, Anna S, Kiesewetter, Barbara, Zeitlinger, Markus, Preusser, Matthias, Raderer, Markus

Get full text

Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel by Bianconi, Daniela, Heller, Gerwin, Spies, Daniel, Herac, Merima, Gleiss, Andreas, Liebmann-Reindl, Sandra, Unseld, Matthias, Kieler, Markus, Scheithauer, Werner, Streubel, Berthold, Zielinski, Christoph C., Prager, Gerald W.

Get full text

VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution by ATEXANDER, Revu Ann, PRAGER, Gerald W, MIHALY-BISON, Judit, UHRIN, Pavet, SUNZENAUER, Stefan, BINDER, Bernd R, SCHÜTZ, Gerhard J, FREISSMUTH, Michael, BREUSS, Johannes M

Get full text

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers by Taghizadeh, Hossein, Mader, Robert M., Müllauer, Leonhard, Fuereder, Thorsten, Kautzky-Willer, Alexandra, Prager, Gerald W.

Get full text

Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein by Prager, Gerald W., Mihaly, Judit, Brunner, Patrick M., Koshelnick, Yuri, Hoyer-Hansen, Gunilla, Binder, Bernd R.

Get full text

A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGEN... by Tabernero, Josep, Yoshino, Takayuki, Stintzing, Sebastian, de Gramont, Aimery, Gibbs, Peter, Jonker, Derek J, Nygren, Peter, Papadimitriou, Christos, Prager, Gerald W, Tell, Roger, Lenz, Heinz-Josef

Get full text

Optimizing the treatment sequence from second-line to third-line therapy in patients with metastatic colorectal cancer by Grothey, Axel, Bekaii-Saab, Tanios S, Yoshino, Takayuki, Prager, Gerald W

Get full text

Optimizing the treatment sequence from second-line to third-line therapy in patients with metastatic colorectal cancer: discussion by Grothey, Axel, Prager, Gerald W, Yoshino, Takayuki, Bekaii-Saab, Tanios S

Get full text

SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment by Bianconi, Daniela, Herac, Merima, Spies, Daniel, Kieler, Markus, Brettner, Robert, Unseld, Matthias, Fürnkranz, Katrin, Famler, Barbara, Schmeidl, Margit, Minichsdorfer, Christoph, Zielinski, Christoph, Heller, Gerwin, Prager, Gerald W.

Get full text

Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients by Bianconi, Daniela, Schuler, Alexandra, Pausz, Clemens, Geroldinger, Angelika, Kaider, Alexandra, Lenz, Heinz-Josef, Kornek, Gabriela, Scheithauer, Werner, Zielinski, Christoph C, Pabinger, Ingrid, Ay, Cihan, Prager, Gerald W

Get full text